What is Cian Healthcare Ltd (542678) share price return in the past 10 years?

Data is not available for this company

What is the share price of Cian Healthcare Ltd (542678)?

Company share prices are keep on changing according to the market conditions. The current trading price of Cian Healthcare Ltd (542678) on 10-Apr-2026 16:59:59 at 16:59 is 8.26.

What is the P/E ratio of Cian Healthcare?

The latest standalone P/E ratio of Cian Healthcare as of 10-Apr-2026 is 0.00.

What is the P/B ratio of Cian Healthcare Ltd (542678)?

The latest standalone P/B ratio of Cian Healthcare Ltd (542678) as of 10-Apr-2026 is 0.83.

What is the 52-week high and low of Cian Healthcare Ltd (542678)?

The 52-week high of Cian Healthcare Ltd (542678) is Rs. 8.26 and the 52-week low is Rs. 3.11.

Cian Healthcare Ltd (542678) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Cian Healthcare Ltd (542678)
Brand: Cian Healthcare

Cian Healthcare Ltd (542678)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 542678 NSE: Pharmaceuticals & Drugs | Small Cap | Cian Healthcare Share Price

Cian Healthcare Ltd (542678)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 542678 NSE: Pharmaceuticals & Drugs | Small Cap | Cian Healthcare Share Price

Key Metrics

Valuation Multiples

Market Cap

₹21 Cr.

Current Price

₹8.3

52-Week Low / High

₹3 / 8

TTM EPS

₹-7.9

TTM Sales

₹30.9 Cr.

Book Value per Share

₹10

P/E Ratio

0.00

Lower than its 5-year historical median

Industry PE

46.5

Price to Book (P/B)

0.83

In line with its 5-year historical median

Price to Sales (P/S)

0.67

In line with its 5-year historical median

EV/EBITDA

-16.20

Lower than its 5-year historical median

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

-57.13%

Underperforms industry median

Return on Capital Employed (ROCE)

-23.38%

Underperforms industry median

Return on Assets (ROA)

-13.77%

Operating Profit Margin

-9.4%

Net Profit Margin

-63.65%

Gross Profit Margin

-15.6%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

-47.44%

Operating Profit Growth (1 Year)

-138.44%

Net Profit Growth (1 Year)

-5141.03%

Asset Quality

Promoter Holding

95.00%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹17 Cr.

Equity

₹25 Cr.

Face Value

₹10

All Time Low / High

₹2.97 / 62.90

Cian Healthcare stock performance

Key Ratios

Check Before You Invest

M-Cap below 100cr DeciZen not available

Q.1 Is Cian Healthcare Ltd a good quality company?

Cian Healthcare Ltd is a quality company, based on a multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Cian Healthcare Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Cian Healthcare Ltd vs industry peers?

Cian Healthcare Ltd revenue CAGR is -11.55%, compared to the industry median CAGR of 5.35%, indicating slower growth and losing its market share.

Q.1 Promoter shareholding and pledge status of Cian Healthcare Ltd?

Promoters hold 95.00% of the Cian Healthcare Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Cian Healthcare Ltd over the last decade?

Over the last 5 year(s), the stock has delivered a CAGR of -12.17% based on the current price.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	14.3%	16.8%	18.8%	9.6%	6.9%	6.8%	2.8%	6.2%	5.5%	-23.4%	-
Value Creation Index ⓘ	0.0	0.2	0.3	-0.3	-0.5	-0.5	-0.8	-0.6	-0.6	-2.7	-
Growth Parameters ⓘ
Sales ⓘ	46.7	51.8	65.9	62.4	57.1	72.4	64.1	67.6	58.8	30.9	31
Sales YoY Gr.	-	10.9%	27.3%	-5.3%	-8.6%	26.9%	-11.4%	5.4%	-13%	-47.4%	-
Adj EPS ⓘ	110.5	165.2	2.4	0.2	-0.1	0.2	-0.9	0.3	0.1	-4.5	-7.9
YoY Gr.	-	49.5%	-98.6%	-91.6%	-170%	NA	-491.7%	NA	-65.6%	-4145.5%	-
BVPS (₹) ⓘ	784.4	949.6	980.9	12.7	22.1	23.3	23	20.6	17.5	10	10
Adj Net Profit ⓘ	1.6	2.3	4	0.4	-0.3	0.6	-2.4	0.8	0.3	-11.1	-20
Cash Flow from Ops. ⓘ	9.9	6	7.7	9.2	-9.2	5.5	5.5	2.2	6.9	20.7	-
Debt/CF from Ops. ⓘ	3.2	6.9	6.5	5.3	-5.5	9	7.8	19.8	5.9	1.9	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	-4.5%	-11.6%	-21.6%	-47.4%
Adj EPS ⓘ	-170%	NA	NA	-4145.5%
BVPSⓘ	-38.4%	-14.7%	-24.2%	-42.9%
Share Price	-	-18.1%	-40.3%	100.5%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	14.1	19.1	25.8	1.8	-0.8	0.9	-3.9	1.3	0.5	-21.4	-78.5
Op. Profit Mgn % ⓘ	16.3	19.5	19.7	12.6	13.5	13.2	7.9	13.4	12.9	-9.4	NAN
Net Profit Mgn % ⓘ	3.3	4.5	6.1	0.6	-0.6	0.8	-3.7	1.2	0.5	-36	-63.6
Debt to Equity ⓘ	2.9	3.1	3.7	2.2	1	0.9	0.8	0.8	0.9	1.6	-
Working Cap Days ⓘ	0	239	218	300	416	361	439	431	483	821	0
Cash Conv. Cycle ⓘ	0	124	159	154	121	112	108	130	184	296	0

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	46.68	51.78	65.90	62.44	57.05	72.38	64.10	67.56	58.75	30.88
Operating Expenses ⓘ +	39.09	41.69	52.93	54.58	49.34	62.99	59.07	58.50	51.18	33.79
Manufacturing Costs	0.11	2.03	3.86	4.93	11.93	13.35	14.85	14.14	15.33	9.04
Material Costs	32.35	33.27	36.01	40.42	26.98	36.05	28.89	30.95	22.77	14.62
Employee Cost	4.18	3.64	3.50	4.78	3.96	6.44	7.72	7.76	7.18	6.51
Other Costs ⓘ	2.44	2.75	9.56	4.44	6.47	7.14	7.61	5.66	5.89	3.61
Operating Profit ⓘ	7.59	10.09	12.97	7.86	7.71	9.39	5.04	9.06	7.57	-2.91
Operating Profit Margin (%)	16.3%	19.5%	19.7%	12.6%	13.5%	13.0%	7.9%	13.4%	12.9%	-9.4%
Other Income ⓘ +	0.47	0.07	0.18	1.02	0.79	0.33	0.47	0.54	1.06	0.25
Exceptional Items ⓘ	0	0	0	-0.04	-0.07	-0.20	-0.07	0.03	0	-12.25
Interest ⓘ	3.98	5.14	5.94	5.52	5.90	6.40	5.25	4.79	4.93	2.16
Depreciation ⓘ	1.93	1.95	1.95	2.39	2.45	2.45	2.57	3.64	3.68	2.61
Profit Before Tax ⓘ	2.16	3.08	5.26	0.94	0.07	0.67	-2.38	1.20	0.01	-19.67
Tax ⓘ	0.61	0.77	1.26	0.29	0.15	0.34	-0.10	0.12	-0.38	-0.02
Profit After Tax	1.55	2.31	4	0.66	-0.07	0.33	-2.28	1.08	0.39	-19.66
PAT Margin (%)	3.3%	4.5%	6.1%	1.1%	-0.1%	0.5%	-3.6%	1.6%	0.7%	-63.7%
Adjusted EPS (₹)	0.9	1.4	2.4	0.4	-0.0	0.1	-0.9	0.4	0.2	-7.9
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Valuation of Cian Healthcare - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	10.98	13.29	17.74	21.70	59.55	59.87	60.35	61.42	61.81	42.16
Share Capital ⓘ	1.40	1.40	1.40	17.14	23.36	23.36	25	25	25	25
Reserves ⓘ	9.58	11.89	16.34	4.56	36.19	36.51	35.35	36.43	36.82	17.16
Debt +	31.06	39.68	50.41	48.66	45.78	39.88	41.12	34.33	36.89	28.93
Long Term Debt	20.36	24	24.60	22.86	24.49	18.37	19.99	12.90	15.29	0.37
Short Term Debt	10.70	15.68	25.81	25.79	21.29	21.50	21.12	21.44	21.60	28.55
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	10.82	2	5.23	15.91	15.99	17.71	28.79	23.63	25.14	33.87
Others Liabilities ⓘ	3.96	6.30	3.20	5.75	13.37	17.17	9.53	21.25	19.06	37.72
Total Liabilities ⓘ	56.82	61.28	76.57	92.02	134.69	134.63	139.78	140.63	142.89	142.68
Fixed Assets
Net Fixed Assets ⓘ +	18.14	21.48	20	23.48	20.78	18.73	32.82	29.42	25.88	23.32
Gross Block	20.59	25.34	25.39	31.21	30.96	31.37	48.03	48.27	47.81	47.85
Accumulated Depreciation	2.45	3.86	5.39	7.73	10.18	12.64	15.20	18.85	21.92	24.53
CWIP ⓘ	5.38	3.69	6.56	6.37	24.80	25.71	13	13.89	14.70	15.07
Investments ⓘ	0	0	0	0	7.09	7.09	7.09	7.09	7.09	7.09
Inventories	12.17	12.30	15.83	15.95	19.72	25.71	34.02	34.81	37.68	25.62
Trade Receivables	12.21	13.74	25.57	22.22	19.95	18.54	18.26	23.54	18.30	15.54
Cash Equivalents	0.57	1.07	0.59	2.33	3.02	2.21	1.22	1.13	0.73	17.66
Others Assets ⓘ	8.34	9	8.02	21.67	39.34	36.65	33.37	30.77	38.51	38.38
Total Assets ⓘ	56.82	61.28	76.57	92.02	134.69	134.63	139.78	140.63	142.89	142.68

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	9.89	6.03	7.74	9.21	-9.24	5.46	5.51	2.15	6.94	20.66
PBT ⓘ	2.16	3.08	5.26	0.94	0.07	0.33	-2.28	1.08	0.39	-19.66
Adjustment ⓘ	5.84	7.09	6.39	7.07	7.90	8.10	7.10	7.60	7.82	4.12
Changes in Working Capital ⓘ	2.56	-3.84	-3.91	1.21	-17.22	-2.96	0.69	-6.53	-1.26	36.19
Tax Paid ⓘ	-0.59	-0.29	0	0	0	0	0	0	0	0
Cash Flow From Investing Activity ⓘ +	-5.08	-4.02	-2.69	-4.69	-25.16	-1.20	-3.85	-1.08	-0.93	-0.27
Capex	-0.80	-3.06	-2.93	-5.90	0.25	-0.41	-16.65	-0.24	-0.15	-0.04
Net Investments	0	0	0	0	0	0	0	0	0	0
Others ⓘ	-4.28	-0.97	0.24	1.22	-25.41	-0.79	12.81	-0.84	-0.78	-0.23
Cash Flow From Financing Activity ⓘ +	-4.74	-1.51	-5.53	-2.78	35.09	-5.07	-2.65	-1.17	-6.41	-3.46
Net Proceeds from Shares ⓘ	1.60	0	0	3.31	37.92	0	2.78	0	0	0
Net Proceeds from Borrowing ⓘ	-1.99	3.64	0.60	-1.73	1.63	-6.12	1.62	-7.09	2.39	-14.91
Interest Paid ⓘ	-3.80	-4.98	-5.94	-4.86	-5.71	-5.84	-4.76	-4.08	-4.36	-1.63
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	-0.55	-0.16	-0.19	0.50	1.25	6.89	-2.29	10.01	-4.44	13.08
Net Cash Flow ⓘ	0.07	0.50	-0.48	1.74	0.69	-0.81	-0.99	-0.10	-0.40	16.93

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	14.09	19.05	29.64	3.7	-0.2	0.62	-4.07	1.98	0.82	-57.13
ROCE (%)	14.28	16.77	18.81	9.6	6.9	6.84	2.81	6.16	5.54	-23.38
Asset Turnover Ratio	0.82	0.88	0.98	0.76	0.51	0.55	0.48	0.49	0.41	0.22
PAT to CFO Conversion(x)	6.38	2.61	1.94	13.95	N/A	16.55	N/A	1.99	17.79	N/A
Working Capital Days
Receivable Days	95.50	91.40	106.70	136.20	134	94.70	102	111.30	130	200
Inventory Days	95.20	86.30	76.40	90.60	113.30	111.80	165.60	183.30	225.20	374.10
Payable Days	122.10	70.30	36.60	95.40	215.70	170.60	293.80	309.10	390.80	736.40

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

34.11

18.02

18.83

47.77

99.87

34.48

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Cian Healthcare Ltd FAQs

The current trading price of Cian Healthcare on 10-Apr-2026 16:59 is ₹8.26.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 09-Apr-2026 the market cap of Cian Healthcare stood at ₹20.65 Cr

The latest P/E ratio of Cian Healthcare as of 09-Apr-2026 is 0.00.

The latest P/B ratio of Cian Healthcare as of 09-Apr-2026 is 0.83.

The 52-week high of Cian Healthcare is ₹8.26 and the 52-week low is ₹3.11.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Cian Healthcare is ₹30.88 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Cian Healthcare Ltd is a average quality company.

The key valuation ratios of Cian Healthcare Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Cian Healthcare Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Cian Healthcare Ltd

No data to display

Cian Healthcare Ltd (542678)

Cian Healthcare Ltd (542678)

Cian Healthcare stock performance

Check Before You Invest

M-Cap below 100cr DeciZen not available

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Cian Healthcare - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Cian Healthcare Ltd FAQs

About Cian Healthcare Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Cian Healthcare Ltd (542678)

Cian Healthcare Ltd (542678)

Cian Healthcare stock performance

Check Before You Invest

M-Cap below 100cr DeciZen not available

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Cian Healthcare - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Cian Healthcare Ltd FAQs

What is the share price of Cian Healthcare?

What is the market cap of Cian Healthcare?

What is the P/E ratio of Cian Healthcare?

What is the P/B ratio of Cian Healthcare?

What is the 52-week high and low of Cian Healthcare?

What is the TTM revenue of Cian Healthcare?

Is Cian Healthcare Ltd a good quality company?

Is Cian Healthcare Ltd undervalued or overvalued?

Is Cian Healthcare Ltd a good buy now?

About Cian Healthcare Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.